BioSig Technologies Files 8-K on Agreements and Equity Sales
Ticker: STEX · Form: 8-K · Filed: Mar 3, 2025 · CIK: 1530766
| Field | Detail |
|---|---|
| Company | Biosig Technologies, Inc. (STEX) |
| Form Type | 8-K |
| Filed Date | Mar 3, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, equity-sale, filing
TL;DR
BioSig filed an 8-K for material agreements & equity sales on Feb 28.
AI Summary
BioSig Technologies, Inc. filed an 8-K on February 28, 2025, reporting on the entry into a material definitive agreement, unregistered sales of equity securities, and financial statements. The filing details events that occurred on February 28, 2025, and was submitted on March 3, 2025. The company is incorporated in Delaware and its principal executive offices are located in Westport, CT.
Why It Matters
This 8-K filing indicates significant corporate actions by BioSig Technologies, Inc., potentially impacting its financial structure and operational agreements.
Risk Assessment
Risk Level: medium — The filing involves material definitive agreements and unregistered sales of equity, which can introduce financial and regulatory risks.
Key Players & Entities
- BioSig Technologies, Inc. (company) — Registrant
- February 28, 2025 (date) — Date of earliest event reported
- March 3, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- Westport, CT (location) — Principal executive offices address
FAQ
What type of material definitive agreement did BioSig Technologies, Inc. enter into?
The filing states the entry into a material definitive agreement but does not specify the nature of the agreement in the provided text.
What was the date of the earliest event reported in the 8-K?
The earliest event reported was on February 28, 2025.
When was this 8-K form filed with the SEC?
The 8-K form was filed on March 3, 2025.
In which state is BioSig Technologies, Inc. incorporated?
BioSig Technologies, Inc. is incorporated in Delaware.
What are the company's principal executive offices?
The company's principal executive offices are located at 12424 Wilshire Blvd, Ste 745, Los Angeles, California, 90025, with a listed business address in Westport, CT.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 3, 2025 regarding BioSig Technologies, Inc. (STEX).